Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2684

Actual shortage: 240 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2435 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

27 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-NABILONE 0.25MG CAPSULE Resolved 2021-11-25 2021-12-02 149942
TEVA-RISPERIDONE 0.25MG TABLET Resolved 2022-06-16 2022-09-08 162861
TEVA-NABILONE 0.25MG CAPSULE Resolved 2022-09-22 2023-04-28 169973
ACT PRAMIPEXOLE 0.25MG TABLET Resolved 2023-04-27 2024-01-11 190719
ACT PRAMIPEXOLE 0.25MG TABLET Resolved 2023-06-19 2023-07-05 195582
TEVA-ROPINIROLE 0.25MG TABLET Resolved 2023-06-26 2023-08-18 196471
TEVA-ROPINIROLE 0.25MG TABLET Actual shortage 2024-02-08 2024-04-25 218977
TEVA-CLONIDINE 0.2MG TABLET Resolved 2023-02-16 2023-10-04 184946
TEVA-CLONIDINE 0.2MG TABLET Resolved 2023-06-20 2023-07-05 195888
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-30 2021-04-01 127616
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-11-06 2021-01-28 128025
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-18 2021-05-13 134343
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-08 2021-05-13 137185
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-12-15 160454
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-04-27 2024-05-09 190785
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-10-06 195078
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-20 2023-07-05 195827
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-11-03 2024-05-03 209148
CEFAZOLIN FOR INJECTION 0.5G POWDER FOR SOLUTION Resolved 2017-05-23 2017-09-19 10877
CEFAZOLIN FOR INJECTION 0.5G POWDER FOR SOLUTION Resolved 2019-06-18 2019-07-15 86966

Showing 161 to 180 of 2684

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
TEVA-CIPROFLOXACIN Discontinued 2018-10-12 2018-10-12 63952
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64526
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64529
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64532
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64535
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64544
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64547
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64550
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64553
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623

Showing 1 to 20 of 250